Publicacións nas que colabora con FELIPE CASANUEVA FREIJO (13)

2023

  1. Natural history and comorbidities of generalised and partial lipodystrophy syndromes in Spain

    Frontiers in Endocrinology, Vol. 14

2021

  1. Variable expressivity in type 2 familial partial lipodystrophy related to r482 and n466 variants in the lmna gene

    Journal of Clinical Medicine, Vol. 10, Núm. 6, pp. 1-9

2018

  1. Bone mineral density in familial partial lipodystrophy

    Clinical Endocrinology, Vol. 88, Núm. 1, pp. 44-50

  2. Inflammatory myopathy in the context of an unusual overlapping laminopathy

    Archives of Endocrinology and Metabolism, Vol. 62, Núm. 3, pp. 376-382

2016

  1. Impact of mean cell hemoglobin on Hb A1c-defined glycemia status

    Clinical Chemistry, Vol. 62, Núm. 12, pp. 1570-1578

  2. Type 1 familial partial lipodystrophy: understanding the Köbberling syndrome

    Endocrine, Vol. 54, Núm. 2, pp. 411-421

2015

  1. Influence of the glycation gap on the diagnosis of type 2 diabetes

    Acta Diabetologica, Vol. 52, Núm. 3, pp. 453-459

  2. Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience

    Endocrine, Vol. 49, Núm. 1, pp. 139-147

2012

  1. Estimation of the glycation gap in diabetic patients with stable glycemic control

    Diabetes Care, Vol. 35, Núm. 12, pp. 2447-2450

  2. Intrapersonal HbA1c variability and the risk of progression of nephropathy in patients with Type2 diabetes

    Diabetic Medicine, Vol. 29, Núm. 12, pp. 1562-1566

2011

  1. Progression of nephropathy in type 2 diabetes: The glycation gap is a significant predictor after adjustment for glycohemoglobin (Hb A1c)

    Clinical Chemistry, Vol. 57, Núm. 2, pp. 264-271

2000

  1. Ghrelin-induced growth hormone secretion in humans

    European Journal of Endocrinology, Vol. 143, Núm. 6

1998

  1. Acute changes in free-fatty acids (FFA) do not alter serum leptin levels

    Journal of Endocrinological Investigation, Vol. 21, Núm. 8, pp. 526-530